Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iRhythm Holdings (IRTC) Cash & Equivalents (2016 - 2026)

iRhythm Holdings has reported Cash & Equivalents over the past 12 years, most recently at $240.1 million for Q1 2026.

  • Quarterly Cash & Equivalents fell 36.01% to $240.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $240.1 million through Mar 2026, down 36.01% year-over-year, with the annual reading at $142.4 million for FY2025, 66.06% down from the prior year.
  • Cash & Equivalents was $240.1 million for Q1 2026 at iRhythm Holdings, up from $142.4 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $550.6 million in Q2 2024 and troughed at $24.7 million in Q3 2022.
  • The 5-year median for Cash & Equivalents is $142.4 million (2025), against an average of $217.0 million.
  • Year-over-year, Cash & Equivalents plummeted 81.33% in 2022 and then soared 1059.97% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $78.8 million in 2022, then crashed by 54.11% to $36.2 million in 2023, then soared by 1059.97% to $419.6 million in 2024, then tumbled by 66.06% to $142.4 million in 2025, then skyrocketed by 68.61% to $240.1 million in 2026.
  • Per Business Quant, the three most recent readings for IRTC's Cash & Equivalents are $240.1 million (Q1 2026), $142.4 million (Q4 2025), and $162.5 million (Q3 2025).